 |
|
(from
www.cancer.org/colonmd)
Colorectal
cancer (commonly referred to as "colon" cancer) develops
in the digestive tract, also referred to as the gastrointestinal,
or GI, tract. The digestive tract processes the food you eat and
rids the body of solid waste matter. This cancer usually develops
from precancerous changes or growths in the lining of these organs.
These growths of tissue protruding into the colon or rectum are
called polyps.
Overall,
colon cancers are the third most common cancers in men and women,
and the second leading cause of cancer death in the United States.
Colon
cancer is the third most common cancer among African American men
and women in the United States.
Colon
cancer is the third most common cancer in Hispanic/Latino men and
the second most common cancer in Hispanic/Latino women in the United
States.
For
2003, an estimated 147,500 new cases will be diagnosed in the United
States. Of these new cancer cases, 105,500 will be colon cancer,
and 42,000 rectal cancer.
An
estimated 57,100 men and women will die of this disease in 2003,
accounting for 10 percent of cancer deaths this year in the United
States.
African
Americans have the highest death rate from colon cancer of any racial
or ethnic group in the United States.
Colon
cancer is the second leading cause of cancer deaths in African American
men and the third leading cause in African American women in the
United States.
Colon
cancer is the third leading cause of cancer deaths in Hispanic/Latino
men and women in the United States.
Age:
The risk of colon cancer increases with age. Nearly 90 percent of
colon cancer patients are over the age of 50.
Race:
African American men and women are at greater risk for developing
and dying from colon cancer than men and women of other racial and
ethnic groups.
Testing
/ Detection
Colorectal
Cancer Fact Sheet
According
to the American Cancer Society guidelines for the early detection
of colon cancer, starting at age 50 both men and women should follow
one of the following testing options:
Note:
Flexible sigmoidoscopy together with FOBT is preferred when compared
to FOBT or flexible sigmoidoscopy alone. All positive tests should
be followed up with colonoscopy. People with a family or personal
history of colon cancer or polyps, or history of chronic inflammatory
bowel disease should be tested earlier, and may need to undergo
testing more often.
- Yearly
fecal occult blood test (FOBT)
- Flexible
sigmoidoscopy every five years
- FOBT
yearly and flexible sigmoidoscopy every five years (preferred
over either option alone)
- Double-contrast
barium enema every five years
- Colonoscopy
every 10 years
Common
Treatments
Survival
Surgery
is the most common form of treatment for colon cancer. For cancers
that have not spread, it frequently stops the disease.
Chemotherapy,
or chemotherapy with radiation treatment, is given before or after
surgery to most patients whose cancer has spread extensively into
the bowel wall or to the lymph nodes.
A
permanent colostomy (creation of an abdominal opening for elimination
of body wastes) is very seldom needed for colon cancer and not often
required for rectal cancer.
Surgery
is the most common form of treatment for colon cancer. For cancers
that have not spread, it frequently stops the disease.
Chemotherapy,
or chemotherapy with radiation treatment, is given before or after
surgery to most patients whose cancer has spread extensively into
the bowel wall or to the lymph nodes.
Risk
Factors (cont.)
Colorectal
Cancer Fact Sheet
Family
History: A personal or family history of colon cancer or polyps
increases the risk of cancer. People with a history of inflammatory
bowel disease also may be at greater risk. In addition, there are
a number of hereditary conditions that increase the risk of colon
cancer, including familial adenomatous polyposis (FAP), hereditary
nonpolyposis colorectal cancer (HNPCC), Gardner's syndrome, and
Ashkenazi Jewish heritage.
Use
of Cigarettes and Other Tobacco Products
Physical
Inactivity
Diet:
A diet high in animal fats, such as those found in red meat, can
increase a person's chance of developing colon cancer.
Symptoms
Early
colon cancer usually has no symptoms. People with the following
symptoms should see their doctor:
Note:
Signs and symptoms of colon cancer typically occur in advanced stages
of the disease.
- A
change in bowel habits, such as diarrhea, constipation, or narrowing
of the stool, that lasts for more than a few days.
- A
feeling that you need to have a bowel movement that doesn't go
away after you do
- Bleeding
from the rectum or blood in the stool
- Cramping
or gnawing stomach pain
- Decreased
appetite
- Weakness
and fatigue
- Jaundice
(yellow-green color of the skin and white part of the eye)
Survival
(cont.)
The
American Cancer Society and Colon Cancer
Colorectal
Cancer Fact Sheet
Once
the cancer has spread to parts of the body that are remote from
the primary tumor, the five-year survival rate is nine percent.
The
American Cancer Society is the nationwide, community-based voluntary
health organization dedicated to eliminating cancer as a major health
problem by preventing cancer, saving lives, and diminishing suffering
from cancer, through research, education, advocacy, and service.
For
more information, call the American Cancer Society at 1-800-ACS-2345
or visit www.cancer.org.
Research:
Currently, the American Cancer Society is funding 94 colon cancer-related
grants totaling approximately $37 million.
Education:
The Society delivers health information to the public so that individuals
can make informed personal decisions. Examples include printed materials,
media coverage, community based outreach programs, and free, nationwide
services such as the www.cancer.org Web site and a 24-hour information
and support line at 1-800-ACS-2345.
Advocacy:
With the help of grassroots volunteers in communities across the
country, the Society advocates action at both the state and federal
levels to ensure responsible health policies and to increase funding
for research and access to early detection and diagnosis tools and
treatment. For example, the American Cancer Society was instrumental
in securing Medicare and Federal Health Employee Benefit Plan coverage
of the full range of colorectal cancer screening tests. The Society
is continuing to lead the charge at the federal and state levels
to ensure all Americans have coverage for the full range of colorectal
colon cancer early detection tests for average-risk people 50 or
older and those at higher risk.
Service:
The Society works to improve quality of life for people living with
cancer through a variety of support services and programs helping
patients and families cope with the disease.
|
|
 |
 |